Antithrombotic properties of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure. [electronic resource]
Producer: 19930107Description: 563-9 p. digitalISSN:- 0340-6245
- Adult
- Aged
- Aged, 80 and over
- Antithrombin III -- metabolism
- Blood Coagulation -- drug effects
- Dermatan Sulfate -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Fibrinolytic Agents -- therapeutic use
- Fibrinopeptide A -- metabolism
- Heparin -- therapeutic use
- Humans
- Kidney Failure, Chronic -- blood
- Male
- Middle Aged
- Peptide Hydrolases -- metabolism
- Renal Dialysis
- Thrombosis -- prevention & control
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.